Skip to main content

Market Overview

Recap: Inspire Medical Systems Q2 Earnings


Shares of Inspire Medical Systems (NYSE:INSP) were flat in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were down 175.00% year over year to ($0.88), which beat the estimate of ($1.10).

Revenue of $12,183,000 declined by 32.44% from the same period last year, which beat the estimate of $7,850,000.


Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

How To Listen To The Conference Call

Date: Aug 04, 2020

Time: 05:00 PM

ET Webcast URL:

Price Action

Company's 52-week high was at $105.53

Company's 52-week low was at $40.53

Price action over last quarter: Up 46.22%

Company Overview

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.


Related Articles (INSP)

View Comments and Join the Discussion!

Posted-In: Earnings